Sanofi diabetes drug Toujeo wins European green light

LONDON, Feb 27 (Reuters) - French drugmaker Sanofi's new Toujeo diabetes drug has been recommended for approval in Europe, two days after being cleared to go on sale in the United States, regulators said on Friday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.